malignant kidney neoplasm

The US Food and Drug Administration (FDA) approved belzutifan (Welireg) for adult patients with von Hippel-Lindau disease (VHL) who require

NEW YORK (Reuters Health) – First-line therapy with a combination of lenvatinib and everolimus had promising anticancer activity in patients